Press release
Spinal Cord Injury - Pipeline Review, H1 2018 by MarketResearchReports.biz
About Spinal Cord Injury Market
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Spinal Cord Injury - Pipeline Review, H1 2018, provides an overview of the Spinal Cord Injury (Central Nervous System) pipeline landscape.
Get Sample copy of this Report @ https://www.marketresearchreports.biz/sample/sample/1731742
Spinal cord injury (SCI) is defined as damage or trauma caused to the spinal cord. SCI can lead to loss or impaired function resulting in reduced mobility or feeling. It is usually caused by trauma, transverse myelitis, polio, spina bifida or Friedreich's ataxia.
Signs and symptoms of spinal cord injury include extreme back pain or pressure in the neck, head or back, paralysis in any part of the body, numbness, tingling or loss of sensation in the hands, fingers, feet or toes, loss of bladder or bowel control, difficulty in walking and impaired breathing after injury.
Report Highlights
Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Spinal Cord Injury - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Spinal Cord Injury (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Spinal Cord Injury (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Spinal Cord Injury and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages are 2, 7, 10, 1, 29 and 4 respectively. Similarly, the Universities portfolio in Phase I and Preclinical stages comprises 1 and 13 molecules, respectively.
Request for TOC @ https://www.marketresearchreports.biz/reports/1731742/spinal-cord-injury-pipeline-review-h1-2018-market-research-reports/toc
Spinal Cord Injury (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Spinal Cord Injury (Central Nervous System).
- The pipeline guide reviews pipeline therapeutics for Spinal Cord Injury (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Spinal Cord Injury (Central Nervous System) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Spinal Cord Injury (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Spinal Cord Injury (Central Nervous System)
Reasons to buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Spinal Cord Injury (Central Nervous System).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and its most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Spinal Cord Injury (Central Nervous System) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
View Report @ https://www.marketresearchreports.biz/reports/1731742/spinal-cord-injury-pipeline-review-h1-2018-market-research-reports
Table of Contents
Table of Contents 2
Introduction 5
Spinal Cord Injury - Overview 6
Spinal Cord Injury - Therapeutics Development 7
Spinal Cord Injury - Therapeutics Assessment 17
Spinal Cord Injury - Companies Involved in Therapeutics Development 27
Spinal Cord Injury - Drug Profiles 41
Spinal Cord Injury - Dormant Projects 172
Spinal Cord Injury - Discontinued Products 177
Spinal Cord Injury - Product Development Milestones 178
Appendix 189
List of Tables
Number of Products under Development for Spinal Cord Injury, H1 2018
Number of Products under Development by Companies, H1 2018
Number of Products under Development by Universities/Institutes, H1 2018
Products under Development by Companies, H1 2018
Products under Development by Universities/Institutes, H1 2018
Number of Products by Stage and Target, H1 2018
Number of Products by Stage and Mechanism of Action, H1 2018
Number of Products by Stage and Route of Administration, H1 2018
Number of Products by Stage and Molecule Type, H1 2018
Spinal Cord Injury - Pipeline by AbbVie Inc, H1 2018
Spinal Cord Injury - Pipeline by Acorda Therapeutics Inc, H1 2018
Spinal Cord Injury - Pipeline by Asterias Biotherapeutics Inc, H1 2018
Spinal Cord Injury - Pipeline by Athersys Inc, H1 2018
Spinal Cord Injury - Pipeline by BioArctic AB, H1 2018
Spinal Cord Injury - Pipeline by BioAxone BioSciences Inc, H1 2018
Spinal Cord Injury - Pipeline by Biogen Inc, H1 2018
Spinal Cord Injury - Pipeline by CSL Ltd, H1 2018
Spinal Cord Injury - Pipeline by CSPC Pharmaceutical Group Limited, H1 2018
Spinal Cord Injury - Pipeline by Genervon Biopharmaceuticals LLC, H1 2018
Spinal Cord Injury - Pipeline by Hemostemix Inc, H1 2018
Spinal Cord Injury - Pipeline by Histocell SL, H1 2018
Spinal Cord Injury - Pipeline by K-Stemcell Co Ltd, H1 2018
Spinal Cord Injury - Pipeline by Kadimastem Ltd, H1 2018
Spinal Cord Injury - Pipeline by Kringle Pharma Inc, H1 2018
Spinal Cord Injury - Pipeline by MandalMed Inc, H1 2018
Spinal Cord Injury - Pipeline by Mapreg SAS, H1 2018
Spinal Cord Injury - Pipeline by Neuralstem Inc, H1 2018
Spinal Cord Injury - Pipeline by Neuronax SAS, H1 2018
Spinal Cord Injury - Pipeline by New World Laboratories Inc, H1 2018
Spinal Cord Injury - Pipeline by Pharmicell Co Ltd, H1 2018
Spinal Cord Injury - Pipeline by PixarBio Corp, H1 2018
Spinal Cord Injury - Pipeline by RDD Pharma Ltd, H1 2018
Spinal Cord Injury - Pipeline by RespireRx Pharmaceuticals Inc, H1 2018
Spinal Cord Injury - Pipeline by SanBio Inc, H1 2018
Spinal Cord Injury - Pipeline by Spectrum Pharmaceuticals Inc, H1 2018
Spinal Cord Injury - Pipeline by Stemedica Cell Technologies Inc, H1 2018
Spinal Cord Injury - Pipeline by Sumitomo Dainippon Pharma Co Ltd, H1 2018
Spinal Cord Injury - Pipeline by TissueGene Inc, H1 2018
Spinal Cord Injury - Pipeline by Tumorend LLC, H1 2018
Spinal Cord Injury - Pipeline by Vertex Pharmaceuticals Inc, H1 2018
Spinal Cord Injury - Pipeline by Vicore Pharma AB, H1 2018
Spinal Cord Injury - Dormant Projects, H1 2018
Spinal Cord Injury - Discontinued Products, H1 2018
List of Figures
Number of Products under Development for Spinal Cord Injury, H1 2018
Number of Products under Development by Companies, H1 2018
Number of Products under Development by Universities/Institutes, H1 2018
Number of Products by Top 10 Targets, H1 2018
Number of Products by Stage and Top 10 Targets, H1 2018
Number of Products by Top 10 Mechanism of Actions, H1 2018
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2018
Number of Products by Routes of Administration, H1 2018
Number of Products by Stage and Routes of Administration, H1 2018
Number of Products by Top 10 Molecule Types, H1 2018
Number of Products by Stage and Top 10 Molecule Types, H1 2018
Buy Now @ https://www.researchmoz.com/checkout?rep_id=1731742&licType=S
About us
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
Contact
Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074
Website: http://www.marketresearchreports.biz/
E: sales@marketresearchreports.biz
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Spinal Cord Injury - Pipeline Review, H1 2018 by MarketResearchReports.biz here
News-ID: 1026218 • Views: …
More Releases from MarketResearchReports.biz
Hydro-flyers Market: Moving Towards a Brighter Future
A hydro-flyer is an adventure sporting device which uses the propulsion of water jet technology to create continuous flight movement, where the lift and movement are controlled by the flyer. Hydro-flyers sporting devices make use of the flow of water power to drive the flyer to reach soaring heights. The rise in water sporting facilities is one of the major factors that promote the growth and demand for hydro-flyers in…
Outdoor Floodlights: Technology and Market Dynamics
Outdoor floodlights is a reliable, highly efficient, and economical solution for a wide range of outdoor applications. These lights are resistant to temperature fluctuations and they remain stable even in extreme climatic conditions. Unlike the traditional lights, floodlights remain stable and functional even in harsh climatic conditions. This makes them ideal for use in any climate and any outdoor application. Outdoor floodlights save a significant amount of energy and consume…
Snow Helmets Market Future Prospects and Regional Outlook
Riders are riding faster and getting bolder day by day. Hence, safety equipment need to be updated as per the requirement and changing time. Earlier, helmets were primarily used by extreme skiers and racers. They were used only on slopes. However, later, the use of helmets was made compulsory. Earlier, bulky black helmets were used by riders, which are outdated at present. Currently, new stylish helmets that can match with…
Predictions for 2019: Global Sparkling Water Dispensers Industry Is Set to Boom
Sparkling water dispensers are equipment used for dispensing carbonated water. These dispensers mix the still, filtered water with carbon dioxide before dispensing. Sparkling water dispensers are mostly used in households and commercial establishments such as amusement parks, hotels, restaurants, and sports arenas. A sparkling water dispenser has separate outlets for hot water and cold water. The hot water outlet does not require a separate filtration process. However, cold water is…
More Releases for Spinal
Spinal Non-Fusion
Spinal implants are devices used for the treatment of spinal disorders such as disproportion and instability of spine. Spine surgical devices are broadly classified into fusion and non-fusion devices. Fusion devices heals by providing immediate and rigid immobilization, and non-fusion devices treats by replacing pro-inflammatory tissues, restoring spinal alignment, and decompressing neural elements while preserving functional movements rather than obliterating it. The advantages such as prolonged recuperation time, bone graft…
Different Approaches to Spinal Fusion Market And Control Spinal Deformity Develo …
Spinal fusion is surgery to permanently join together two or more bones in the spine so there is no movement between them. For patients who require spinal fusion surgery to treat lumbar degenerative disc disease (DDD), spinal fusion device is a treatment option.
Spinal fusion has been used for many years to treat many painful conditions in the lumbar (lower) spine. Over the past decade, there has been dramatic improvement in…
Spinal Cord Compression-Spinal Stenosis Market Progresses for Huge Profits by 20 …
The Global Spinal Cord Compression-Spinal Stenosis Market is expected to reach $ 8.5 billion by the end of 2023, this market is projected to growing at a CAGR of ~ 11.5 % during 2017-2023.
Spinal stenosis is the abnormal narrowing of spinal canal causing it to restrict, which may result in a neurological deficit due to interference with neurological fibres. The associated symptoms include pain, numbness, loss of motor control etc.…
Spinal Cord Compression-Spinal Stenosis Market Report: Industry Manufacturers An …
Marketresearchfuture.com includes Global Spinal Cord Compression-Spinal Stenosis Market by indications, by diagnosis, by end users - Global Forecast till 2023 is new report.
Spinal cord compression is the second most frequent neurologic complication of cancer. Only in the United States, each year nearly 20,000 people with cancer develop spinal cord compression; this affected population represents 5% to 10% of the general cancer population.
Request Sample copy of Spinal cord compression-spinal stenosis…
Spinal Trauma Devices Market: Spinal Trauma Devices Sales to Surge Rapidly in Re …
The global spinal trauma devices market is dynamic and highly competitive. Only a couple of companies account for a substantial share in the market, thus lending it an oligopolistic vendor landscape. The market is largely dominated by DePuy Synthes, Medtronic, NuVasive, Inc., Stryker Corporation, and Globus Medical, Inc. The cumulative share of these companies added up to 79.1% in 2014, says Transparency Market Research (TMR) in a new report.
As…
Spinal Implants and Spinal Devices Market Analysis, Development and Demand Forec …
The global spinal implants and spinal devices market is growing, due to increasing demand for minimally invasive surgeries, increasing number of hospitals and surgical centers, and commercial applications in areas, such as nucleus arthroplasty, stem cell technology and artificial disk replacement. The spinal fusion and fixation technology dominates the market and the non-fusion/ motion preservation technology segment is expected to grow with the fastest rate during the forecast period, due…
